Tag Archives: TGTX

Hot Clean Energy Stocks To Own Right Now

Shah Gilani

Every week, I publish a “watchlist” of stocks for my Total Wealth free e-letter subscribers. It’s just like how it sounds; they’re stocks I’m keeping tabs on because I see the potential for big, imminent moves. That’s also why I talk about speculative trades people can execute to cash in on those moves.

My editor, though, asked me to share this week’s watchlist with everybody because it’s packed with clean energy stocks.

Thanks to the infrastructure bill, and what will likely be billions and billions in earmarks, the whole sector is heating up. There’s also a great deal of global growth here, outside of the United States, as the world transitions away from fossil fuels. Be that as it may, choosing the right stocks here can mean the difference between missing out, or collecting ho-hum profits, and knocking it out of the park.

Hot Clean Energy Stocks To Own Right Now: TG Therapeutics, Inc.(TGTX)

TG Therapeutics, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases primarily in the United States. It develops TG-1101 (ublituximab), a novel glycol engineered monoclonal antibody that targets a epitope on the CD20 antigen found on the surface of B-lymphocytes developed to aid in the depletion of circulating B-cells; and TG-1101 in combination with TGR-1202 for relapsed/refractory non-Hodgkins lymphoma and chronic lymphocytic leukemia. The company also develops TGR-1202, an orally available phosphoinositide-3-kinase delta inhibitor with nanomolar potency to the delta isoform and high selectivity over the alpha, beta, and gamma isoforms, as well as for hematologic malignancies. In addition, it develops a pre-clinical program to develop the inhibitors of interleukin-1 receptor-associated kinase 4 (IRAK4); and anti-PD-L1 and anti-GITR antibody research programs that are in pre-clinical development stage in the field of hematological malignancies. The company has license agreements with LFB Biotechnologies S.A.S, GTC Biotherapeutics, LFB/GTC LLC, and Ildong Pharmaceutical Co. Ltd. for the development and commercialization of TG-1101; Rhizen Pharmaceuticals, SA for the development and commercialization of TGR-1202; and Ligand Pharmaceuticals Incorporated for the development and commercialization of IRAK4 inhibitor technology. It also has a collaboration agreement with Checkpoint Therapeutics, Inc. for the development and commercialization of anti-PD-L1 and anti-GITR antibody research programs in the field of hematological malignancies. TG Therapeutics, Inc. is headquartered in New York, New York.

Advisors’ Opinion:

  • [By Todd Campbell]

    Fueled by trial data,TG Therapeutics (NASDAQ:TGTX)shares skyrocketed 69.5% in February, according to S&P Global Market Intelligence.

    So what

    On Jan. 30, data from phase 1 trials evaluating TG Therapeutics’ ublituximab and umbralisib alongside J&Jand AbbVie’sImbruvica was published in Lancet, a respected industry journal.

  • [By Logan Wallace]

    Shares of TG Therapeutics Inc (NASDAQ:TGTX) have received a consensus rating of “Buy” from the eight research firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and six have given a buy recommendation to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $12.30.

  • [By George Budwell]

    Shares of the B-cell malignancy and autoimmune disease specialist TG Therapeutics (NASDAQ:TGTX) fell by an eye-popping 55.9% last month, according to data fromS&P Global Market Intelligence. What triggered this dramatic sell-off?

Hot Clean Energy Stocks To Own Right Now: ClearOne Communications Inc.(CLRO)

ClearOne Communications, Inc., a communications solutions company, develops and sells conferencing, collaboration, and streaming multimedia systems for audio, video, and Web applications. It develops, manufactures, markets, and services a line of audio conferencing products for personal, tabletop, premium, and professional uses by businesses and organizations, such as enterprise, healthcare, education and distance learning, government, legal, and finance organizations. The company also offers various residential products under the NetStreams DigilinX brand and commercial products under the VIEW brand, which deliver the Internet protocol (IP) A/V experience by streaming high definition audio and video, and control over TCP/IP networks. Its audio and video, and control solutions support virtually various digital or analog sources, including high definition audio and video content sources, and an unlimited number of networked end points on existing IP networks and infrastruct ure. In addition, the company manufactures and sells media carts for audio and video conferencing. It serves end-users, including small and medium-sized businesses, educational institutions, government organizations, and individual consumers primarily through a network of independent distributors who in turn sell the products to dealers, systems integrators, and other value-added resellers, as well as through a network of residential electronics dealers. ClearOne Communications, Inc. was founded in 1983 and is headquartered in Salt Lake City, Utah.

Advisors’ Opinion:

  • [By Stephan Byrd]

    Akoustis Technologies (NASDAQ: CLRO) and Clearone (NASDAQ:CLRO) are both small-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, analyst recommendations, risk, earnings and profitability.

  • [By Ethan Ryder]

    Fabrinet (NASDAQ: CLRO) and Clearone (NASDAQ:CLRO) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, dividends, profitability, risk, earnings, analyst recommendations and institutional ownership.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Clearone (CLRO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Clean Energy Stocks To Own Right Now: Moelis & Company(MC)

Moelis & Company is a leading global independent investment bank that provides innovative strategic and financial advice to a diverse client base, including corporations, governments and financial sponsors. We assist our clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all major industry sectors. Our team of experienced professionals advises clients on their most critical decisions, including mergers and acquisitions (“M&A”), recapitalizations and restructurings and other corporate finance matters.
Moelis & Company was founded in 2007 by veteran investment bankers to create a global independent investment bank that offers multi-disciplinary solutions and exceptional transaction execution combined with the highest standard of confidentiality and discretion.   Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Moelis & Company (NYSE:MC)Q42018 Earnings Conference CallFeb. 06, 2019, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Logan Wallace]

    Moelis & Co (NYSE:MC) has been given an average recommendation of “Buy” by the seven ratings firms that are currently covering the firm, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $62.17.

  • [By Max Byerly]

    MAN Grp PLC/ADR (NYSE: MC) and Moelis & Co (NYSE:MC) are both mid-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership.

Hot Clean Energy Stocks To Own Right Now: (RUP)

Rupert Resources Ltd. is a gold exploration and development company. The Company is engaged in the acquisition and exploration of mineral properties in Canada. The Company is seeking out mineral exploration and evaluation opportunities and has over two projects located in Ontario and British Columbia. The Company’s exploration and evaluation assets include Pahtavaara gold mine, Gold Centre Property and Surf Inlet Property. The Pahtavaara Mine is located in the Central Lapland Greenstone Belt in Northern Finland. The Company holds interest in a 20-year mining lease consisting of mineral claims located in the Balmer Township, Red Lake Mining Division of Ontario, subject to approximately 1.5% net smelter returns royalty (NSR). The Company holds interest in the Surf Inlet Gold property on Princess Royal Island, British Columbia, consisting of approximately 20 Crown Grants and over nine mineral tenures on the property covering a total area of approximately 870 hectares.
Advisors’ Opinion:

  • [By Stephan Byrd]

    Rupee (CURRENCY:RUP) traded down 0.9% against the U.S. dollar during the one day period ending at 14:00 PM ET on October 12th. Rupee has a total market capitalization of $802,724.00 and $4.00 worth of Rupee was traded on exchanges in the last day. During the last seven days, Rupee has traded 0% lower against the U.S. dollar. One Rupee coin can now be purchased for approximately $0.0323 or 0.00000515 BTC on exchanges including CoinExchange and CryptoBridge.

  • [By Max Byerly]

    Rupee (CURRENCY:RUP) traded 10.1% higher against the US dollar during the 24 hour period ending at 16:00 PM ET on September 23rd. Over the last week, Rupee has traded 73.1% higher against the US dollar. One Rupee coin can now be bought for $0.0169 or 0.00000252 BTC on major exchanges including CoinExchange and CryptoBridge. Rupee has a total market capitalization of $415,606.00 and approximately $267.00 worth of Rupee was traded on exchanges in the last day.

  • [By Stephan Byrd]

    Rupert Resources Ltd (CVE:RUP) insider Alan Douglas Brimacombe sold 30,000 shares of the business’s stock in a transaction dated Thursday, August 9th. The shares were sold at an average price of C$0.95, for a total value of C$28,500.00.

Hot Clean Energy Stocks To Own Right Now: Henry Schein, Inc.(HSIC)

We believe we are the world’s largest provider of health care products and services primarily to office-based dental, animal health and medical practitioners. We serve more than 1 million customers worldwide including dental practitioners and laboratories, animal health clinics and physician practices, as well as government, institutional health care clinics and other alternate care clinics. We believe that we have a strong brand identity due to our more than 83 years of experience distributing health care products.   Advisors’ Opinion:

  • [By Michael A. Robinson]

    And in late February, General Electric Co. (NYSE:GE) completed the $2.9 billion spin-off of its transportation unit. Just three weeks before that, medical distributor Henry Schein Inc. (Nasdaq: HSIC) shed its animal health business and completed a merger to create Covetrus Inc. (Nasdaq:CVET) in a deal valued at up to $1.2 billion.

  • [By Stephan Byrd]

    TRADEMARK VIOLATION WARNING: “2,495 Shares in Henry Schein, Inc. (HSIC) Acquired by AGF Investments Inc.” was reported by Ticker Report and is owned by of Ticker Report. If you are reading this news story on another publication, it was copied illegally and republished in violation of international copyright law. The original version of this news story can be viewed at www.tickerreport.com/banking-finance/4188612/2495-shares-in-henry-schein-inc-hsic-acquired-by-agf-investments-inc.html.

Hot Clean Energy Stocks To Own Right Now: Spirit Airlines Inc.(SAVE)

Spirit Airlines, Inc. provides passenger airline services. It provides travel opportunities principally to and from south Florida, the northeast United States, the Caribbean, and Latin America. The company also offers optional travel-related products or services. As of December 31, 2011, it had a fleet of 37 Airbus single-aisle aircrafts. The company was formerly known as Charter One and changed its name to Spirit Airlines, Inc. in 1992. Spirit Airlines, Inc. was founded in 1964 and is headquartered in Miramar, Florida.

Advisors’ Opinion:

  • [By Adam Levine-Weinberg]

    In late 2016, I wrote that shares of Spirit Airlines (NYSE:SAVE) could reach $100 by 2020. Since then, there’s been a lot of movement — both up and down — for Spirit Airlines stock, but the share price is almost exactly back where it started.

  • [By Adam Levine-Weinberg]

    In the first few years after its 2011 IPO, Spirit Airlines (NYSE:SAVE) seemed practically invincible. The carrier used its rock-bottom cost structure to undercut traditional airlines’ fares, enabling it to quickly gain market share while producing industry-leading margins.

Top 10 Medical Stocks To Own Right Now

Primo Water (NASDAQ:PRMW) had its price objective hoisted by analysts at BMO Capital Markets from $15.00 to $16.00 in a research note issued on Thursday. The firm currently has a “market perform” rating on the stock. BMO Capital Markets’ price target points to a potential upside of 0.88% from the company’s current price.

PRMW has been the subject of a number of other research reports. ValuEngine upgraded shares of Primo Water from a “sell” rating to a “hold” rating in a research note on Wednesday, May 2nd. BidaskClub lowered shares of Primo Water from a “hold” rating to a “sell” rating in a research note on Tuesday, March 13th. Barrington Research restated a “buy” rating and set a $20.00 price target on shares of Primo Water in a research note on Friday, April 6th. B. Riley set a $18.00 price target on shares of Primo Water and gave the company a “buy” rating in a research note on Monday, March 5th. Finally, William Blair began coverage on shares of Primo Water in a research note on Thursday. They set an “outperform” rating for the company. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $17.50.

Top 10 Medical Stocks To Own Right Now: THL Credit Senior Loan Fund(TSLF)

THL Credit Senior Loan Fund is a non-diversified, closed-end management investment company (Fund). The Fund’s investment objective is to provide current income and preservation of capital primarily through investments in United States dollar-denominated senior secured corporate loans and notes. Under normal market conditions, the Fund will invest 100% of its Managed Assets in the securities of issuers located in North America and does not currently intend to invest a material amount of its Managed Assets outside the United States. It invests in sectors, such as Business, Services, Healthcare and Pharmaceuticals, Retail, Software, Advertising, Printing and Publishing, and Diversified and Services, among others. Four Wood Capital Advisors LLC serves as the Fund’s investment adviser. Advisors’ Opinion:

Top 10 Medical Stocks To Own Right Now: Catalyst Biosciences, Inc. (CBIO)

Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on engineering proteases as therapeutics for hemophilia, hemeostasis, complement-mediated diseases, and other unmet medical needs. Its product pipeline includes CB 813d, a Factor VIIa drug candidate that completed a Phase I clinical trials evaluating safety and tolerability, as well as pharmacokinetics, pharmacodynamics, and coagulation activity in severe hemophilia A and B patients with and without inhibitors. The company’s preclinical development stage drugs comprise CB 2679d/ISU 304, a next-generation Factor IX drug for the treatment of patients with hemophilia B; and a Factor Xa variant. It is also developing CB 2782, an anti-C3 inflammation development candidate for the treatment of delayed graft function in kidney transplants; and an ophthalmic anti-C3 candidate for treatment of dry age-related macular degeneration. The company has collaboration agreement with Pfizer, Inc. for the development of human Factor VIIa products; and ISU Abxis for development and manufacturing of the Factor IX products through Phase I/II clinical trials. Catalyst Biosciences, Inc. is headquartered in South San Francisco, California.

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Catalyst Biosciences (CBIO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Chris Lange]

    Catalyst Biosciences Inc. (NASDAQ: CBIO) is scheduled to present interim data from its Phase 2 study of Marzeptacog alfa (MarzAA) on July 18. This data will be pertaining to the subcutaneous efficacy trial in individuals with hemophilia A or B with inhibitors to evaluate the ability of MarzAA to minimize spontaneous bleeding episodes.

  • [By Joseph Griffin]

    B. Riley lowered shares of Catalyst Biosciences (NASDAQ:CBIO) from a buy rating to a neutral rating in a research report released on Thursday, MarketBeat reports. They currently have $12.50 price objective on the biopharmaceutical company’s stock, down from their prior price objective of $44.00.

  • [By Cory Renauer]

    If you’re looking for biotech stock bargains, the scrap heap isn’t a bad place to start. Hardly a day goes by without a biotech meltdown somewhere, and clinical trial mishaps led to market clubbings for Anika Therapeutics (NASDAQ:ANIK) and Catalyst Biosciences (NASDAQ:CBIO) earlier this week.

Top 10 Medical Stocks To Own Right Now: RELX PLC(RELX)

RELX Group is a global provider of information and analytics for professional and business customers across industries.
Our goal is to help customers make better decisions, get better results and be more productive. We do this by leveraging a deep understanding of our customers to create innovative solutions which combine content and data with analytics and technology in global platforms.
The Group has customers in more than 180 countries and has offices in about 40 countries. The Group employs approximately 30,000 staff.
We operate in four major market segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions.

? Scientific, Technical & Medical helps customers advance science and improve healthcare by providing information and analytical solutions that enable them to make critical decisions, enhance productivity, and improve outcomes.   Advisors’ Opinion:

  • [By Joseph Griffin]

    First Republic Investment Management Inc. acquired a new position in shares of Relx PLC (NYSE:RELX) in the 2nd quarter, Holdings Channel reports. The fund acquired 13,205 shares of the technology company’s stock, valued at approximately $287,000.

  • [By Joseph Griffin]

    Relx PLC (NYSE:RELX)’s share price reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as $20.27 and last traded at $20.29, with a volume of 6975 shares traded. The stock had previously closed at $20.35.

  • [By Joseph Griffin]

    Relx (NYSE: RELX) and Cambium Learning Group (NASDAQ:ABCD) are both computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings and analyst recommendations.

Top 10 Medical Stocks To Own Right Now: Cherry Hill Mortgage Investment Corporation(CHMI)

Cherry Hill Mortgage Investment Corporation, incorporated on October 31, 2012, is a residential real estate finance company. The Company is focused on acquiring, investing in and managing residential mortgage assets in the United States. Its principal objective is to generate attractive current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The Company focuses on attaining this objective, subject to market conditions and availability and terms of financing, by selectively constructing and managing a targeted portfolio of Servicing Related Assets, residential mortgage-backed securities (RMBS), prime mortgage loans and other cashflowing residential mortgage assets. The Company operates its business through segments, including investments in RMBS; investments in Servicing Related Assets, and All Other. The Company’s targeted asset classes include servicing related assets consisting of mortgage servicing rights (MSRs) and Excess MSRs; RMBS, including Agency RMBS, residential mortgage pass-through certificates, collateralized mortgage obligations (CMOs) (interest-only security (IO) and inverse IOs) and to-be-announced (TBA), and prime mortgage loans. The Company is externally managed by Cherry Hill Mortgage Management, LLC.

The Company also may generate MSRs through the purchase of prime mortgage loans. Its RMBS strategy focuses primarily on the acquisition and ownership of Agency RMBS that are whole-pool, residential mortgage pass-through certificates. However, from time to time, the Company invests in CMOs, including IOs and inverse IOs. Its RMBS strategy includes selective investments in non-Agency RMBS, including government-sponsored enterprise (GSE) risk-sharing securities.

Advisors’ Opinion:

  • [By Max Byerly]

    Cherry Hill Mortgage Investment (NYSE:CHMI) and Great Portland Estates (OTCMKTS:GPEAF) are both finance companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, profitability, institutional ownership and valuation.

  • [By Ethan Ryder]

    Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of Cherry Hill Mortgage Investment Corp (NYSE:CHMI) during the 2nd quarter, according to its most recent disclosure with the SEC. The fund acquired 152,335 shares of the real estate investment trust’s stock, valued at approximately $2,721,000. Connor Clark & Lunn Investment Management Ltd. owned approximately 0.98% of Cherry Hill Mortgage Investment as of its most recent filing with the SEC.

Top 10 Medical Stocks To Own Right Now: Briggs & Stratton Corporation(BGG)

Briggs & Stratton Corporation designs, manufactures, markets, sells, and services air cooled gasoline engines for outdoor power equipment. It operates in two segments, Engines and Products. The Engines segment offers four-cycle aluminum alloy gasoline engines that are used primarily by the lawn and garden equipment industry. Its products are used in various lawn and garden equipment applications, including walk-behind lawn mowers, riding lawn mowers, garden tillers, and snow throwers, as well as products for industrial, construction, agricultural, and other consumer applications that include portable and standby generators, pumps, and pressure washers. This segment also manufactures and sells replacement engines and service parts to sales and service distributors. The Products segment offers portable and standby generators, pressure washers, snow throwers, lawn and garden powered equipment, turf care, and job site products. This segment sells its products through various channels of retail distribution, including consumer home centers, warehouse clubs, mass merchants, and independent dealers under its brands, including Briggs & Stratton, Simplicity, Snapper, Snapper Pro, Ferris, PowerBoss, Allmand, Billy Goat, Murray, Branco, and Victa, as well as other brands, such as Craftsman, GE, and Troy-Bilt. The company serves original equipment manufacturers worldwide. Briggs & Stratton Corporation was founded in 1908 and is headquartered in Wauwatosa, Wisconsin.

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Briggs & Stratton (BGG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Jon C. Ogg]

    Generac Holdings Inc. (NYSE: GNRC) was up less than 1% at $59.20 late on Tuesday, but that is actually up by over 6% from last Friday’s close for the generator maker before the storm threat was so imminent. Briggs & Stratton Corp. (NYSE: BGG) is also in that field and its gain of just 0.3% to $20.45 late on Tuesday was actually up only about 1% from last Friday as the company is more diversified

  • [By Motley Fool Transcriber]

    Briggs & Stratton Corporation (NYSE: BGG)Q4 2018 Briggs & Stratton Corp Earnings CallAug. 16, 2018, 2 p.m. EDT

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 10 Medical Stocks To Own Right Now: EP Energy Corporation(EPE)

EP Energy Corporation (EP Energy), incorporated on August 8, 2013, is an independent exploration and production company. The Company is engaged in the acquisition and development of unconventional onshore oil and natural gas properties in the United States. The Company operates through a diverse base of producing assets and are focused on creating value through the development of its drilling inventory located in four areas: the Eagle Ford Shale (South Texas), the Wolfcamp Shale (Permian Basin in West Texas), the Altamont Field in the Uinta Basin (Northeastern Utah) and the Haynesville Shale (North Louisiana). In its operating areas, it has identified approximately 5,710 drilling locations (including over 860 drilling locations to which it has attributed proved undeveloped reserves).

The Company has proved reserves of approximately 546.0 million barrels of oil equivalent (MMBoe) and it has an average net daily production of over 109,680 barrel of oil equivalent per day (Boe/d). Approximately 240 MMBoe of its total proved reserves are proved developed producing assets, which generates an average production of over 109.7 million barrels of oil equivalent per day (MBoe/d) from approximately 1,600 wells. The Company has approximately 300 MMBbls of proved oil reserves, over 90 MMBbls of proved natural gas liquids (NGLs) reserves and approximately 940 billion cubic feet (Bcf) of proved natural gas reserves.

Eagle Ford Shale

The Eagle Ford Shale, located in South Texas, is an unconventional oil plays in the United States. The Eagle Ford formation in La Salle county has approximately 120 feet of net thickness (over 160 feet gross). The Company has approximately 94,150 net (over 88,890 gross) acres in the Eagle Ford, in which it has identified over 970 drilling locations. The Company has approximately 570 net producing wells (over 560 net operated wells) and running one rig in this program. EP Energy’s average net daily production is approximately 58,190 Boe/d.

!

Wolfcamp Shale

The Wolfcamp Shale is located in the Permian Basin. The Wolfcamp A, B and C zones combine for over 750 feet of net (approximately 1,000 feet of gross) thickness. The Company has approximately 178,110 net (over 178,280 gross) acres in the Wolfcamp, in which it has identified approximately 3,260 drilling locations in the Wolfcamp A, B and C zones. EP Energy has approximately 240 net operated producing wells. Its average net daily production is over 19,850 Boe/d.

Altamont

The Altamont field is located in the Uinta Basin in northeastern Utah. The Company’s operations are focused on developing the Altamont Field Complex (consisting of the Altamont, Bluebell and Cedar Rim fields). It owns approximately 180,940 net (over 323,210 gross) acres in Duchesne and Uinta Counties. The Altamont Field Complex has a gross pay interval thickness of over 4,300 feet. Its commingled production is from over 1,500 feet of net stimulated rock. The Company’s activity is focused on the development of its vertical inventory on approximately 80-acre and 160-acre spacing. The Company has identified approximately 1,280 drilling locations. EP Energy has approximately 390 net producing wells (over 380 net operated wells). The Company’s average net daily production is approximately 17,140 Boe/d.

Haynesville Shale

The Company holds natural gas assets in the Haynesville Shale, located in East Texas and Northern Louisiana. The Company’s operations are concentrated primarily in Desoto Parish, Louisiana in the Holly Field. It has approximately 34,170 net (over 52,930 gross) acres in this area. EP Energy has identified over 190 drilling locations. The Company’s average net daily production is approximately 90 million cubic feet per day (MMcf/d).

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    EP Energy Corp  (NYSE:EPE)Q4 2018 Earnings Conference CallMarch 15, 2019, 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Enterprise GP (EPE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Enterprise GP Holdings L.P. (NYSE:EPE) shares were up 5.5% during trading on Wednesday . The stock traded as high as $2.55 and last traded at $2.51. Approximately 939,243 shares traded hands during mid-day trading, a decline of 13% from the average daily volume of 1,077,065 shares. The stock had previously closed at $2.38.

Top 10 Medical Stocks To Own Right Now: MuniVest Fund, Inc.(MVF)

BlackRock MuniVest Fund, Inc. (the Fund), formerly known as MuniVest Fund, Inc., is a non-diversified, closed-end management investment company. The Fund seeks to provide a high a level of current income exempt from federal income taxes by investing primarily in a portfolio of long-term, investment-grade municipal obligations, the interest on which is exempt from federal income taxes.

BlackRock MuniVest Fund, Inc. may invest in certain securities, whose income return is inversely related to changes in a floating interest rate (inverse floaters). The Fund may invest in swap agreements. The Fund may also purchase and write call and put options. BlackRock MuniVest Fund, Inc.’s investment advisor is BlackRock Advisors, LLC, a wholly owned subsidiary of BlackRock, Inc. The Fund’s sub-advisor is BlackRock Investment Management, LLC.

Advisors’ Opinion:

  • [By Max Byerly]

    BlackRock MuniVest Fund Inc. (NYSEAMERICAN:MVF) declared a monthly dividend on Thursday, September 6th, Wall Street Journal reports. Stockholders of record on Friday, September 14th will be paid a dividend of 0.041 per share by the investment management company on Monday, October 1st. This represents a $0.49 annualized dividend and a dividend yield of 5.57%. The ex-dividend date of this dividend is Thursday, September 13th.

Top 10 Medical Stocks To Own Right Now: Basilea Pharmaceutica Ltd. (BPMUF)

Basilea Pharmaceutica AG is a Switzerland-based company engaged in the research, development and commercialization of pharmaceutical products. The Company focuses on pharmaceutical products in the therapeutic areas of bacterial infections, fungal infections and oncology. The Company has a range of drugs to treat drug-resistant bacterial infections, systemic fungal infections and drug-resistant tumors. The Company’s anti-infectives, including isavuconazole and ceftobiprole are in late-stage clinical development, while the novel antibiotic, BAL30072 and the oncology compound, BAL101553 are in clinical phase I. The Company’s subsidiaries include Basilea Pharmaceutica China Ltd., Basilea Pharmaceuticals A/S, Basilea Pharma SAS, Basilea Pharmaceutica Deutschland GmbH, Basilea Pharmaceutica International Ltd., BPh Investitionen Ltd., Basilea Medical Ltd. and Basilea Pharmaceuticals Ltd. Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Basilea Pharmaceutica (BPMUF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    Basilea Pharmaceuticals (OTC:BPMUF)

    BPMUF Is a Swiss company with commercialized products in the anti-infection space, but they are also working on agents in cancer research. One of these agents, BAL101553, is a prodrug of a so-called “tumor checkpoint controller” inhibitor, which destabilizes microtubules to disrupt dividing cells. This phase 1/2a study assessed the safety and the recommended dosage for this agent. The phase 1 portion of the trial recruited 20 patients to receive various doses of BAL101553.

Top 10 Medical Stocks To Own Right Now: SunCoke Energy Partners, L.P.(SXCP)

SunCoke Energy Partners, L.P., (the “Partnership,” “we,” “our” and “us”), is a Delaware limited partnership formed in July 2012, which primarily produces coke used in the blast furnace production of steel. We also provide coal handling and/or mixing services at our Coal Logistics terminals. At December 31, 2015, we owned a 98.0 percent interest in Haverhill Coke Company LLC (“Haverhill”), Middletown Coke Company, LLC (“Middletown”) and Gateway Energy and Coke Company, LLC (“Granite City”). At December 31, 2015, SunCoke Energy, Inc. (“SunCoke”) owned the remaining 2.0 percent interest in each of Haverhill, Middletown, and Granite City, and, through its subsidiary, owned a 53.9 percent partnership interest in us and all of our incentive distribution rights and indirectly owns and controls our general partner, which holds a 2.0 percent general partner interest in us. Coke is a principal raw material in the blast furnace steelmaking process.   Advisors’ Opinion:

  • [By Stephan Byrd]

    Bramshill Investments LLC cut its stake in SunCoke Energy Partners LP (NYSE:SXCP) by 4.0% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 113,454 shares of the energy company’s stock after selling 4,786 shares during the period. Bramshill Investments LLC’s holdings in SunCoke Energy Partners were worth $1,702,000 as of its most recent SEC filing.

  • [By Shane Hupp]

    SunCoke Energy Partners (NYSE:SXCP) was upgraded by analysts at ValuEngine from a sell rating to a hold rating.

    Teligent (NASDAQ:TLGT) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

  • [By Stephan Byrd]

    Here are some of the media stories that may have effected Accern’s analysis:

    Get SunCoke Energy Partners alerts:

    SunCoke Energy Partners LP Declares Quarterly Dividend of $0.40 (SXCP) (americanbankingnews.com) SunCoke Energy Partners (SXCP) Scheduled to Post Earnings on Wednesday (americanbankingnews.com) SunCoke Energy Partners LP (SXCP) Receives Consensus Rating of “Hold” from Brokerages (americanbankingnews.com) Head to Head Survey: SunCoke Energy Partners (SXCP) vs. APERAM/SH N Y REGISTRY SH (APEMY) (americanbankingnews.com)

    Shares of SunCoke Energy Partners traded down $0.05, hitting $15.85, during trading on Friday, MarketBeat reports. 105,181 shares of the company were exchanged, compared to its average volume of 66,406. The firm has a market capitalization of $735.01 million, a price-to-earnings ratio of 9.61 and a beta of 1.44. SunCoke Energy Partners has a fifty-two week low of $14.70 and a fifty-two week high of $21.95. The company has a quick ratio of 0.83, a current ratio of 1.54 and a debt-to-equity ratio of 1.34.

  • [By Shane Hupp]

    SunCoke Energy Partners (NYSE: SXCP) and AK Steel (NYSE:AKS) are both small-cap oils/energy companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.

Top 10 Medical Stocks To Own Right Now: TG Therapeutics, Inc.(TGTX)

TG Therapeutics, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases primarily in the United States. It develops TG-1101 (ublituximab), a novel glycol engineered monoclonal antibody that targets a epitope on the CD20 antigen found on the surface of B-lymphocytes developed to aid in the depletion of circulating B-cells; and TG-1101 in combination with TGR-1202 for relapsed/refractory non-Hodgkin’s lymphoma and chronic lymphocytic leukemia. The company also develops TGR-1202, an orally available phosphoinositide-3-kinase delta inhibitor with nanomolar potency to the delta isoform and high selectivity over the alpha, beta, and gamma isoforms, as well as for hematologic malignancies. In addition, it develops a pre-clinical program to develop the inhibitors of interleukin-1 receptor-associated kinase 4 (IRAK4); and anti-PD-L1 and anti-GITR antibody research programs that are in pre-clinical development stage in the field of hematological malignancies. The company has license agreements with LFB Biotechnologies S.A.S, GTC Biotherapeutics, LFB/GTC LLC, and Ildong Pharmaceutical Co. Ltd. for the development and commercialization of TG-1101; Rhizen Pharmaceuticals, SA for the development and commercialization of TGR-1202; and Ligand Pharmaceuticals Incorporated for the development and commercialization of IRAK4 inhibitor technology. It also has a collaboration agreement with Checkpoint Therapeutics, Inc. for the development and commercialization of anti-PD-L1 and anti-GITR antibody research programs in the field of hematological malignancies. TG Therapeutics, Inc. is headquartered in New York, New York.

Advisors’ Opinion:

  • [By Todd Campbell]

    Fueled by trial data, TG Therapeutics (NASDAQ:TGTX) shares skyrocketed 69.5% in February, according to S&P Global Market Intelligence.

    So what

    On Jan. 30, data from phase 1 trials evaluating TG Therapeutics’ ublituximab and umbralisib alongside J&J and AbbVie’s Imbruvica was published in Lancet, a respected industry journal. 

  • [By Logan Wallace]

    Shares of TG Therapeutics Inc (NASDAQ:TGTX) have received a consensus rating of “Buy” from the eight research firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and six have given a buy recommendation to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $12.30.

  • [By George Budwell]

    Shares of the B-cell malignancy and autoimmune disease specialist TG Therapeutics (NASDAQ:TGTX) fell by an eye-popping 55.9% last month, according to data from S&P Global Market Intelligence. What triggered this dramatic sell-off?

Top 10 High Tech Stocks To Watch For 2019

When Apple (NASDAQ:AAPL) introduced the iPhone 6 series smartphones back in September 2014, the devices came in two different screen options. The standard-sized model with a 4.7-inch display was called iPhone 6 and the larger one with a 5.5-inch display was marketed as the iPhone 6 Plus. 

Apple continued to offer both screen sizes for several subsequent generations, including the iPhone 6s, iPhone 7, and iPhone 8 product families.

Image source: Apple.

Last year, alongside the iPhone 8 product family, Apple introduced a radically redesigned device, called the iPhone X. This device came in only a single screen size: 5.8 inches. While the iPhone X has done well for the company, there’s clearly an opportunity for Apple to appeal to a broader set of potential customers by introducing a larger-screen version of the iPhone X. 

Top 10 High Tech Stocks To Watch For 2019: Veritiv Corporation(VRTV)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Dean Foods Company (NYSE: DF) is projected to report quarterly earnings at $0.11 per share on revenue of $1.85 billion.
    Discovery, Inc. (NASDAQ: DISCA) is expected to report quarterly earnings at $0.44 per share on revenue of $1.99 billion.
    Jacobs Engineering Group Inc. (NYSE: JEC) is estimated to report quarterly earnings at $0.89 per share on revenue of $3.63 billion.
    Henry Schein, Inc. (NASDAQ: HSIC) is expected to report quarterly earnings at $0.92 per share on revenue of $3.17 billion.
    Gartner, Inc. (NYSE: IT) is projected to report quarterly earnings at $0.57 per share on revenue of $926.18 million.
    The AES Corporation (NYSE: AES) is estimated to report quarterly earnings at $0.24 per share on revenue of $2.98 billion.
    Expeditors International of Washington, Inc. (NASDAQ: EXPD) is projected to report quarterly earnings at $0.64 per share on revenue of $1.71 billion.
    US Foods Holding Corp. (NYSE: USFD) is expected to report quarterly earnings at $0.32 per share on revenue of $5.98 billion.
    DISH Network Corporation (NASDAQ: DISH) is expected to report quarterly earnings at $0.7 per share on revenue of $3.50 billion.
    Zebra Technologies Corporation (NASDAQ: ZBRA) is estimated to report quarterly earnings at $2.06 per share on revenue of $936.98 million.
    Camping World Holdings, Inc. (NYSE: CWH) is expected to report quarterly earnings at $0.42 per share on revenue of $1.06 billion.
    Perrigo Company plc (NYSE: PRGO) is projected to report quarterly earnings at $1.14 per share on revenue of $1.21 billion.
    Petróleo Brasileiro S.A. – Petrobras (NYSE: PBR) is estimated to report quarterly earnings at $0.28 per share on revenue of $23.80 billion.
    JD.com, Inc. (NYSE: JD) is projected to report quarterly earnings at $0.18 per share on revenue of $15.65 billion.
    Valeant Pharmaceuticals International, Inc. (NYSE: VRX) is projected to report quarterly earnings at $0.6 per share o
  • [By Shane Hupp]

    Veritiv (NYSE:VRTV) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

    Western Gas Partners (NYSE:WES) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

  • [By Max Byerly]

    Veritiv Corp (NYSE:VRTV) has been assigned a consensus recommendation of “Hold” from the eight research firms that are presently covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $33.50.

Top 10 High Tech Stocks To Watch For 2019: Synacor, Inc.(SYNC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    SVMK (NASDAQ:SVMK) and Synacor (NASDAQ:SYNC) are both small-cap computer and technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, earnings, dividends and institutional ownership.

  • [By Joseph Griffin]

    Syncona Ltd (LON:SYNC) announced a dividend on Thursday, June 14th, Upcoming.Co.Uk reports. Investors of record on Thursday, June 21st will be paid a dividend of GBX 2.30 ($0.03) per share on Monday, July 30th. This represents a yield of 1.02%. The ex-dividend date is Thursday, June 21st. The official announcement can be seen at this link.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Synacor (SYNC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Media coverage about Synacor (NASDAQ:SYNC) has trended somewhat positive recently, according to Accern. The research group identifies positive and negative press coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Synacor earned a coverage optimism score of 0.05 on Accern’s scale. Accern also assigned news coverage about the information services provider an impact score of 47.6409011491603 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

  • [By Shane Hupp]

    HealthStream (NASDAQ: SYNC) and Synacor (NASDAQ:SYNC) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, dividends, risk and profitability.

Top 10 High Tech Stocks To Watch For 2019: Allscripts Healthcare Solutions, Inc.(MDRX)

Advisors’ Opinion:

  • [By Logan Wallace]

    Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) saw unusually large options trading activity on Tuesday. Stock investors purchased 1,317 put options on the company. This represents an increase of 2,211% compared to the typical daily volume of 57 put options.

  • [By Joseph Griffin]

    Shares of Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) have received an average recommendation of “Buy” from the eighteen ratings firms that are presently covering the firm, MarketBeat.com reports. Four research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $16.51.

  • [By Lisa Levin] Gainers
    Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) rose 34.7 percent to $45.50 in pre-market trading following news that the FDA has approved Andexxa for the reversal of factor Xa inhibitors.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) rose 15.7 percent to $6.65 in pre-market trading after climbing 155.56 percent on Thursday.
    China Recycling Energy Corporation (NASDAQ: CREG) rose 14.7 percent to $2.75 in pre-market trading after climbing 57.89 percent on Thursday.
    Pandora Media, Inc. (NYSE: P) rose 11 percent to $6.40 in pre-market trading after reporting strong quarterly results.
    Fred's, Inc. (NASDAQ: FRED) rose 9.2 percent to $1.90 in pre-market trading following Q4 results.
    Shake Shack Inc (NYSE: SHAK) rose 9.1 percent to $51.70 in pre-market trading after the company reported upbeat results for its first quarter and raised its FY18 guidance.
    Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) rose 9 percent to $12.55 in pre-market trading after the company posted Q1 results and agreed to acquire HealthGrid.
    Weight Watchers International, Inc. (NYSE: WTW) rose 7.6 percent to $75 in pre-market trading after the company reported stronger-than-expected results for its first quarter. The company also raised its FY18 earnings outlook from $2.40-$2.70 to $3-$3.20.
    Viavi Solutions Inc. (NASDAQ: VIAV) rose 7.5 percent to $10.15 in pre-market trading following Q3 results.
    Pearson plc (NYSE: PSO) rose 4.5 percent to $11.83 in pre-market trading after reporting strong quarterly earnings.
    Alibaba Group Holding Ltd (NYSE: BABA) shares rose 4.4 percent to $190.50 in the pre-market trading session as the company posted upbeat Q4 results.
    Aqua Metals, Inc. (NASDAQ: AQMS) shares rose 3.9 percent to $4.30 in pre-market trading after gaining 6.98 percent on Thursday.
    Newell Brands Inc (NYSE: NWL) shares rose 3.6 percent to $27.65 in pre-market trading after reporting upbeat quarterly earnings.
    HMS Holdings Corp (NASDAQ: H
  • [By Brian Feroldi]

    Shares of Allscripts Healthcare Solutions (NASDAQ:MDRX), an information technology company focused on the healthcare industry, are up 11% as of 11:30 a.m. EDT. The double-digit gain is attributable to its release of mostly positive second-quarter results. 

  • [By Ethan Ryder]

    ValuEngine upgraded shares of Allscripts Healthcare Solutions (NASDAQ:MDRX) from a sell rating to a hold rating in a research note published on Thursday.

Top 10 High Tech Stocks To Watch For 2019: Smith Micro Software Inc.(SMSI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Okta (NASDAQ: OKTA) and Smith Micro Software (NASDAQ:SMSI) are both computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability.

  • [By Stephan Byrd]

    These are some of the news stories that may have impacted Accern’s scoring:

    Get Smith Micro Software alerts:

    Short Interest in Smith Micro Software (SMSI) Increases By 51.9% (americanbankingnews.com) Smith Micro Software’s (SMSI) CEO Bill Smith on Q1 2018 Results – Earnings Call Transcript (seekingalpha.com) Smith Micro Software (SMSI) Reports Q1 Loss of $0.10 (streetinsider.com) Smith Micro Reports First Quarter 2018 Financial Results (finance.yahoo.com) Smith Micro announces above market USD 7.0m private placement offering (financial-news.co.uk)

    Separately, ValuEngine upgraded shares of Smith Micro Software from a “sell” rating to a “hold” rating in a report on Friday, February 2nd.

  • [By Ethan Ryder]

    Connecture (OTCMKTS: CNXR) and Smith Micro Software (NASDAQ:SMSI) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, profitability, dividends, valuation, analyst recommendations and earnings.

Top 10 High Tech Stocks To Watch For 2019: PGT, Inc.(PGTI)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on PGT Innovations (PGTI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on PGT Industries (PGTI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Jon C. Ogg]

    There is also a boost to windows, doors, and roofing. JELD-WEN Holding, Inc. (NYSE: JELD) was up 2.4% at $26.05 late on Tuesday, but that is a gain of over 5% from last Friday for the doors and windows maker. PGI Innovations, Inc. (NASDAQ: PGTI) had been up as high as $26.40 earlier on Tuesday, but the last look of being down 1% at $25.95 was still up over 2% from last Friday.

  • [By Ethan Ryder]

    Laurion Capital Management LP lessened its stake in PGT Innovations Inc (NYSE:PGTI) by 52.6% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 40,603 shares of the construction company’s stock after selling 45,000 shares during the quarter. Laurion Capital Management LP owned 0.08% of PGT Innovations worth $847,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    PGT Innovations (NYSE:PGTI) and Griffon (NYSE:GFF) are both small-cap construction companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, profitability, dividends, institutional ownership, risk and earnings.

  • [By Ethan Ryder]

    Griffon (NYSE:GFF) and PGT Innovations (NYSE:PGTI) are both small-cap multi-sector conglomerates companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, analyst recommendations, profitability, dividends and risk.

Top 10 High Tech Stocks To Watch For 2019: TGC Industries Inc.(TGE)

Advisors’ Opinion:

  • [By Matthew DiLallo, Travis Hoium, and Todd Campbell]

    Three stocks that aren’t even on Wall Street’s radar yet are Tallgrass Energy (NYSE:TGE), Invitae Corporation (NYSE:NVTA), and MGM Resorts (NYSE:MGM). Here’s why these three Motley Fool contributors think these stocks could open up the door for investors who are looking where others aren’t to potentially earn some outsized gains. 

  • [By Matthew DiLallo]

    Tallgrass Energy (NYSE:TGE) is one of several pipeline companies that emerged from the rubble of the oil market downturn very different from how they entered it. Like many of its peers, Tallgrass recently consolidated its corporate structure by acquiring its master limited partnership (MLP). That transaction strengthened its financial profile. And that positions the company to deliver a sustainable income stream with significant upside potential from expansion projects coming down the pipeline, making it a much more appealing option for income seekers.

  • [By Matthew DiLallo]

    Tallgrass Energy (NYSE:TGE) is a relative unknown in the energy sector. While the company operates one of the more important natural gas pipelines in the country, investors have yet to catch on to its story. Because of that, shares of the pipeline company are cheap, which positions investors to potentially capture meaningful gains if the discount between its peers narrows. Add in a monster dividend and significant upside from some expansion projects it has in development, and Tallgrass Energy could deliver attention-grabbing returns in the coming years.

  • [By Logan Wallace]

    Tallgrass Energy (NYSE: TGE) is one of 34 publicly-traded companies in the “Natural gas transmission” industry, but how does it contrast to its peers? We will compare Tallgrass Energy to related companies based on the strength of its institutional ownership, dividends, analyst recommendations, risk, profitability, valuation and earnings.

Top 10 High Tech Stocks To Watch For 2019: Advanced Drainage Systems, Inc.(WMS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Advanced Drainage Systems (NYSE:WMS) had its target price hoisted by equities researchers at Robert W. Baird from $29.00 to $32.00 in a report issued on Wednesday. The firm currently has an “outperform” rating on the construction company’s stock. Robert W. Baird’s price target points to a potential upside of 10.15% from the company’s previous close.

  • [By Motley Fool Staff]

    Advanced Drainage Systems (NYSE:WMS) Q4 2018 Earnings Conference CallMay. 29, 2018 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Lisa Levin] Companies Reporting Before The Bell
    Booz Allen Hamilton Holding Corporation (NYSE: BAH) is estimated to report quarterly earnings at $0.46 per share on revenue of $1.67 billion.
    Momo Inc. (NASDAQ: MOMO) is projected to report quarterly earnings at $0.5 per share on revenue of $396.17 million.
    Multi-Color Corporation (NASDAQ: LABL) is expected to report quarterly earnings at $1.06 per share on revenue of $424.96 million.
    American Woodmark Corporation (NASDAQ: AMWD) is estimated to report quarterly earnings at $1.15 per share on revenue of $382.4 million.
    The Bank of Nova Scotia (NYSE: BNS) is projected to report quarterly earnings at $1.32 per share on revenue of $5.46 billion.
    Jianpu Technology Inc. (NYSE: JT) is expected to report quarterly loss at $0.04 per share on revenue of $47.51 million.
    Trans World Entertainment Corporation (NASDAQ: TWMC) is estimated to report earnings for its first quarter.
    Advanced Drainage Systems, Inc. (NYSE: WMS) is estimated to report quarterly loss at $0.06 per share on revenue of $249.44 million.
    Quotient Limited (NASDAQ: QTNT) is expected to report quarterly loss at $0.48 per share on revenue of $5.73 million.
    Elbit Systems Ltd. (NASDAQ: ESLT) is projected to report earnings for its first quarter.
    Evogene Ltd. (NASDAQ: EVGN) is expected to report earnings for its first quarter.

     

Top 10 High Tech Stocks To Watch For 2019: TG Therapeutics, Inc.(TGTX)

Advisors’ Opinion:

  • [By Chris Lange]

    TG Therapeutics Inc. (NASDAQ: TGTX) has final Phase 2 data from its trial of ublituximab (TG-1101) in relapsing forms of multiple sclerosis in October. The company will make an oral presentation at the upcoming 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), which will be held on October 10 to 12.

  • [By Cory Renauer]

    The closing weeks of summer could heat up for a few biotechs with experimental new therapies getting close to the finish line. TG Therapeutics, Inc. (NASDAQ:TGTX) and Sangamo Therapeutics, Inc. (NASDAQ:SGMO) will reveal some hotly anticipated clinical trial results in the weeks ahead. Akcea Therapeutics, Inc. (NASDAQ:AKCA) is a lot closer to commercializing its first product in the U.S., but it’s still relying on two approval decisions in its near future.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on TG Therapeutics Inc common stock (TGTX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Todd Campbell]

    After reporting that it will no longer consider an accelerated pathway to approval of a combination drug therapy in clinical trials, TG Therapeutics (NASDAQ:TGTX) shares are tumbling 34% at 11:30 a.m. EDT on Tuesday.

  • [By George Budwell]

    Shares of the B-cell malignancy and autoimmune disease specialist TG Therapeutics (NASDAQ:TGTX) fell by an eye-popping 55.9% last month, according to data from S&P Global Market Intelligence. What triggered this dramatic sell-off?

  • [By Cory Renauer]

    This year’s biggest oncology conference delivered some surprises and gave investors plenty to look forward to in the months ahead. Loxo Oncology Inc. (NASDAQ:LOXO), and TG Therapeutics (NASDAQ:TGTX) are already having a great year that could get a lot better, while recently beaten down Nektar Therapeutics (NASDAQ:NKTR) will get a chance to redeem itself.

Top 10 High Tech Stocks To Watch For 2019: ESSA Pharma Inc.(EPIX)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on ESSA Pharma (EPIX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on ESSA Pharma (EPIX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on ESSA Pharma (EPIX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Avid Bioservices (NASDAQ:CDMO) and ESSA Pharma (NASDAQ:EPIX) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, risk, dividends, institutional ownership and profitability.

Top 10 High Tech Stocks To Watch For 2019: Neuralstem, Inc.(CUR)

Advisors’ Opinion:

  • [By Logan Wallace]

    Pluristem Therapeutics (NASDAQ: CUR) and Neuralstem (NASDAQ:CUR) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership and profitability.

  • [By Logan Wallace]

    Shares of Neuralstem, Inc. (NASDAQ:CUR) were down 16% during mid-day trading on Friday . The stock traded as low as $1.24 and last traded at $1.37. Approximately 595,500 shares were traded during mid-day trading, an increase of 205% from the average daily volume of 195,111 shares. The stock had previously closed at $1.63.

Best Insurance Stocks To Own For 2019

Amarillo National Bank raised its position in iShares S&P 500 Value ETF (NYSEARCA:IVE) by 5.7% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 123,840 shares of the company’s stock after buying an additional 6,639 shares during the quarter. iShares S&P 500 Value ETF comprises about 6.7% of Amarillo National Bank’s portfolio, making the stock its 4th largest holding. Amarillo National Bank’s holdings in iShares S&P 500 Value ETF were worth $14,346,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in the business. Northern Trust Corp grew its holdings in shares of iShares S&P 500 Value ETF by 12.9% during the 1st quarter. Northern Trust Corp now owns 58,230 shares of the company’s stock valued at $6,367,000 after purchasing an additional 6,650 shares during the last quarter. Blair William & Co. IL grew its holdings in shares of iShares S&P 500 Value ETF by 5.6% during the 1st quarter. Blair William & Co. IL now owns 15,855 shares of the company’s stock valued at $1,734,000 after purchasing an additional 834 shares during the last quarter. The Manufacturers Life Insurance Company grew its holdings in shares of iShares S&P 500 Value ETF by 22.2% during the 1st quarter. The Manufacturers Life Insurance Company now owns 154,815 shares of the company’s stock valued at $16,928,000 after purchasing an additional 28,085 shares during the last quarter. Ancora Advisors LLC bought a new stake in shares of iShares S&P 500 Value ETF during the 1st quarter valued at approximately $244,000. Finally, Jane Street Group LLC grew its holdings in shares of iShares S&P 500 Value ETF by 140.7% during the 1st quarter. Jane Street Group LLC now owns 2,358 shares of the company’s stock valued at $258,000 after purchasing an additional 8,153 shares during the last quarter.

Best Insurance Stocks To Own For 2019: TG Therapeutics, Inc.(TGTX)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on TG Therapeutics (TGTX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By George Budwell]

    Shares of the B-cell malignancy and autoimmune disease specialist TG Therapeutics (NASDAQ:TGTX) fell by an eye-popping 55.9% last month, according to data from S&P Global Market Intelligence. What triggered this dramatic sell-off?

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on TG Therapeutics Inc common stock (TGTX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Insurance Stocks To Own For 2019: Endocyte, Inc.(ECYT)

Advisors’ Opinion:

  • [By Cory Renauer]

    If these high-flying drugmakers are going to continue their climb, they have to cross some well-defined hurdles in front of them. Here’s a look at what’s ahead.

    Company (Symbol) 1-Year Gain Recent Market Cap
    Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) 535% $1.8 billion
    Viking Therapeutics, Inc. (NASDAQ:VKTX) 880% $725 million
    Endocyte, Inc. (NASDAQ:ECYT) 1,140% $1.2 billion

    Data source: Yahoo! Finance.

  • [By ]

    Exploding biotech names are nothing new to this bull market. You might recall the headline swirling around Endocyte Inc. (NASDAQ:ECYT) as it posted one-day gains of more than 150% during the fourth quarter. The triple-digit move was sparked by a licensing agreement for the firm’s phase 3 prostate cancer drug. Now, these moves are becoming almost commonplace.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Endocyte (ECYT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Endocyte, Inc. (NASDAQ:ECYT) gapped up prior to trading on Tuesday . The stock had previously closed at $16.70, but opened at $18.00. Endocyte shares last traded at $19.49, with a volume of 145358 shares changing hands.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Endocyte (ECYT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Keith Speights]

    Shares of Innovate Biopharmaceuticals (NASDAQ:INNT), Arrowhead Pharmaceuticals (NASDAQ:ARWR), and Endocyte (NASDAQ:ECYT) have more than tripled in the first six months of 2018. What caused these biotech stocks to skyrocket — and are they still buys now?  

Best Insurance Stocks To Own For 2019: VOC Energy Trust(VOC)

Advisors’ Opinion:

  • [By Shane Hupp]

    Deutsche Bank AG reduced its position in VOC Energy Trust (NYSE:VOC) by 64.5% in the 4th quarter, Holdings Channel reports. The firm owned 19,000 shares of the oil and gas producer’s stock after selling 34,500 shares during the period. Deutsche Bank AG’s holdings in VOC Energy Trust were worth $112,000 as of its most recent filing with the SEC.

Top Heal Care Stocks To Invest In Right Now

Schwab Charles Investment Management Inc. raised its position in shares of Horizon Pharma PLC (NASDAQ:HZNP) by 9.0% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 957,489 shares of the biopharmaceutical company’s stock after purchasing an additional 78,688 shares during the quarter. Schwab Charles Investment Management Inc.’s holdings in Horizon Pharma were worth $13,597,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of the business. D.A. Davidson & CO. purchased a new position in shares of Horizon Pharma in the first quarter worth $143,000. BlueCrest Capital Management Ltd bought a new position in Horizon Pharma during the fourth quarter valued at $160,000. Zweig DiMenna Associates LLC bought a new position in Horizon Pharma during the first quarter valued at $156,000. K2 Principal Fund L.P. increased its position in Horizon Pharma by 126.1% during the fourth quarter. K2 Principal Fund L.P. now owns 11,074 shares of the biopharmaceutical company’s stock valued at $162,000 after acquiring an additional 53,574 shares during the last quarter. Finally, Zeke Capital Advisors LLC bought a new position in shares of Horizon Pharma in the fourth quarter worth about $167,000. 85.17% of the stock is currently owned by institutional investors and hedge funds.

Top Heal Care Stocks To Invest In Right Now: Akamai Technologies, Inc.(AKAM)

Advisors’ Opinion:

  • [By ]

    There could be a for sale sign planted in the ground at tech pioneer Akamai (AKAM) .

    “We’re a public company and our board, which is very professional and diligent, is always going to do the right thing for shareholders,” Akamai CEO Tom Leighton told TheStreet when asked if the company he co-founded in 1998 was for sale. While Leighton left the door open on a possible sale, he added that Akamai has strong prospects as a stand-alone company as well.

  • [By ]

    Meanwhile, Akamai’s (AKAM) CEO Tom Leighton didn’t shut the door to a potential sale of the company in an interview with me. Recent speculation on Wall Street is that Akamai would be an ideal fit for IBM (IBM) . 

  • [By ]

    Akamai (AKAM) CEO Tom Leighton is fresh off a battle with well-known activist investor firm Elliott Management. Leighton discusses the situation with Elliott and prospects for doing deals with TheStreet. 

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Thursday was Akamai Technologies, Inc. (NASDAQ: AKAM) which rose about 7% to $74.89. The stocks 52-week range is $44.65 to $75.00. Volume was roughly 4 million compared to the daily average volume of 2.3 million.

  • [By Anders Bylund]

    During the first quarter, Limelight settledthe last of its legal battles with rival Akamai Technologies (NASDAQ:AKAM). The terms of this settlement were not publicly addressed, but Limelight was the plaintiff and Akamai the defendant in the last patent infringement case, though Akamai also returned fire with several counterclaims. If the settlement had any financial effects, we’ll see those on Akamai’s and Limelight’s financial statements over time. If not, the two companies just removed a source of financial uncertainty.

Top Heal Care Stocks To Invest In Right Now: Evolving Systems, Inc.(EVOL)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Evolving Systems (NASDAQ: EVOL) and Zscaler (NASDAQ:ZS) are both computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, earnings, risk, profitability, institutional ownership, dividends and valuation.

Top Heal Care Stocks To Invest In Right Now: TG Therapeutics, Inc.(TGTX)

Advisors’ Opinion:

  • [By Todd Campbell]

    After reporting solid safety results for umbralisib as a monotherapy in chronic lymphocytic leukemia (CLL) patients who are intolerant to prior BTK (Imbruvica) or PI3K delta inhibitor (Zydelig) therapy,TG Therapeutics (NASDAQ:TGTX)10.8% on Monday.

  • [By Ethan Ryder]

    TG Therapeutics, Inc (NASDAQ:TGTX) was down 6.5% during mid-day trading on Tuesday . The stock traded as low as $11.35 and last traded at $12.57. Approximately 1,971,105 shares were traded during mid-day trading, an increase of 37% from the average daily volume of 1,433,791 shares. The stock had previously closed at $13.45.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on TG Therapeutics Inc common stock (TGTX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Cory Renauer]

    This year’s biggest oncology conference delivered some surprisesand gave investors plenty to look forward to in the months ahead. Loxo Oncology Inc. (NASDAQ:LOXO), andTG Therapeutics(NASDAQ:TGTX) are already having a great year that could get a lot better, while recently beaten downNektar Therapeutics(NASDAQ:NKTR) will get a chance to redeem itself.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on TG Therapeutics (TGTX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Heal Care Stocks To Invest In Right Now: Vanguard Mega Cap Growth ETF (MGK)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Fernwood Investment Management LLC lessened its stake in VANGUARD MEGA CAP 300 GROWTH ETF (BMV:MGK) by 9.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 17,022 shares of the company’s stock after selling 1,698 shares during the period. VANGUARD MEGA CAP 300 GROWTH ETF comprises 1.1% of Fernwood Investment Management LLC’s portfolio, making the stock its 26th biggest holding. Fernwood Investment Management LLC owned approximately 0.06% of VANGUARD MEGA CAP 300 GROWTH ETF worth $1,911,000 as of its most recent filing with the SEC.

Top Heal Care Stocks To Invest In Right Now: Provident Financial Holdings, Inc.(PROV)

Advisors’ Opinion:

  • [By Max Byerly]

    News articles about Provident Financial (NASDAQ:PROV) have been trending somewhat negative this week, according to Accern. Accern identifies negative and positive media coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Provident Financial earned a daily sentiment score of -0.02 on Accern’s scale. Accern also assigned news articles about the financial services provider an impact score of 45.9215692366566 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

  • [By Logan Wallace]

    Charter Financial (NASDAQ: CHFN) and Provident Financial (NASDAQ:PROV) are both small-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.

Top Heal Care Stocks To Invest In Right Now: Polar Power, Inc. (POLA)

Advisors’ Opinion:

  • [By Shane Hupp]

    Polar Power (NASDAQ: POLA) and Ultralife (NASDAQ:ULBI) are both small-cap utilities companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation.

  • [By Shane Hupp]

    Polar Power (NASDAQ:POLA) was upgraded by stock analysts at ValuEngine from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Wednesday.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Polar Power (POLA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com